These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 26222726)

  • 21. The expression of CD30 based on immunohistochemistry predicts inferior outcome in patients with diffuse large B-cell lymphoma.
    Hao X; Wei X; Huang F; Wei Y; Zeng H; Xu L; Zhou Q; Feng R
    PLoS One; 2015; 10(5):e0126615. PubMed ID: 25974110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of BAFF-R, but not BAFF, is an independent prognostic factor in diffuse large B-cell lymphoma patients treated with R-CHOP.
    Wang Y; Li YJ; Jiang WQ; Rao HL; Huang JJ; Xia Y; Bi X; Sun P; Huang HQ; Lin TY; Guan ZZ; Li ZM
    Ann Hematol; 2015 Nov; 94(11):1865-73. PubMed ID: 26327569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response and survival benefit with chemoimmunotherapy in Epstein-Barr virus-positive diffuse large B-cell lymphoma.
    Beltran BE; Quiñones P; Morales D; Malaga JM; Chavez JC; Sotomayor EM; Castillo JJ
    Hematol Oncol; 2018 Feb; 36(1):93-97. PubMed ID: 28639256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of EBV-encoded small RNA targeted PCR to classify EBV positive diffuse large B-cell lymphoma (DLBCL) of the elderly.
    Lee J; Park M; Lee MH; Woo HJ; Kim HW; Yang JY; Eom YB; Kim SH; Yoo C; Kim JB
    Int J Clin Exp Pathol; 2015; 8(7):7859-68. PubMed ID: 26339350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EBV-positive diffuse large B-cell lymphoma of the elderly: 2016 update on diagnosis, risk-stratification, and management.
    Castillo JJ; Beltran BE; Miranda RN; Young KH; Chavez JC; Sotomayor EM
    Am J Hematol; 2016 May; 91(5):529-37. PubMed ID: 27093913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lenalidomide combined with R-CHOP overcomes negative prognostic impact of non-germinal center B-cell phenotype in newly diagnosed diffuse large B-Cell lymphoma: a phase II study.
    Nowakowski GS; LaPlant B; Macon WR; Reeder CB; Foran JM; Nelson GD; Thompson CA; Rivera CE; Inwards DJ; Micallef IN; Johnston PB; Porrata LF; Ansell SM; Gascoyne RD; Habermann TM; Witzig TE
    J Clin Oncol; 2015 Jan; 33(3):251-7. PubMed ID: 25135992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epstein-Barr virus-negative diffuse large B-cell lymphoma hosts intra- and peritumoral B-cells with activated Epstein-Barr virus.
    Stuhlmann-Laeisz C; Szczepanowski M; Borchert A; Brüggemann M; Klapper W
    Virchows Arch; 2015 Jan; 466(1):85-92. PubMed ID: 25339301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma.
    Tisi MC; Cupelli E; Santangelo R; Maiolo E; Alma E; Giachelia M; Martini M; Bellesi S; D'Alò F; Voso MT; Pompili M; Leone G; Larocca LM; Hohaus S
    Leuk Lymphoma; 2016; 57(3):628-34. PubMed ID: 26458141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary Gastric EBV-positive Diffuse Large B Cell Lymphoma (DLBCL) of the Elderly with Plasmablastic Differentiation.
    Hu M; Trevino J; Yang L; Cao D; Liu X; Lai J
    In Vivo; 2018; 32(2):413-417. PubMed ID: 29475930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunophenotypes and prognosis of diffuse large B-cell lymphoma: a study of 500 cases].
    Luo DL; Liu YH; Zhuang HG; Li L; Xu FP; Zhang F; Luo XL; Xu J
    Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):235-9. PubMed ID: 21615996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A study on nm23-H1 expression in diffuse large B-cell lymphoma that was treated with CyclOBEAP plus rituximab therapy.
    Niitsu N; Tamaru J; Yoshino T; Nakamura N; Nakamura S; Ohshima K; Nakamine H; Okamoto M
    Ann Hematol; 2011 Feb; 90(2):185-92. PubMed ID: 20809421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [EBV-positive diffuse large B-cell lymphoma in young individual: report of a case].
    Li WS; Xie JL; Zhang M; Zhou XG
    Zhonghua Bing Li Xue Za Zhi; 2013 Feb; 42(2):128-9. PubMed ID: 23710923
    [No Abstract]   [Full Text] [Related]  

  • 33. Epstein-Barr virus involvement is a predictive factor for the resistance to chemoradiotherapy of gastric diffuse large B-cell lymphoma.
    Yoshino T; Nakamura S; Matsuno Y; Ochiai A; Yokoi T; Kitadai Y; Suzumiya J; Tobinai K; Kobayashi Y; Oda I; Mera K; Ohtsu A; Ishikura S
    Cancer Sci; 2006 Feb; 97(2):163-6. PubMed ID: 16441428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Matched-pair analysis comparing the outcomes of primary breast and nodal diffuse large B-cell lymphoma in patients treated with rituximab plus chemotherapy.
    Yhim HY; Kim JS; Kang HJ; Kim SJ; Kim WS; Choi CW; Eom HS; Kim JA; Lee JH; Won JH; Shim H; Huh J; Lee DH; Suh C; Kwak JY
    Int J Cancer; 2012 Jul; 131(1):235-43. PubMed ID: 21823120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reappraisal of Epstein-Barr virus (EBV) in diffuse large B-cell lymphoma (DLBCL): comparative analysis between EBV-positive and EBV-negative DLBCL with EBV-positive bystander cells.
    Ohashi A; Kato S; Okamoto A; Inaguma Y; Satou A; Tsuzuki T; Emi N; Okamoto M; Nakamura S
    Histopathology; 2017 Jul; 71(1):89-97. PubMed ID: 28231401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma: Is It Different between Over and Under 50 Years of Age?
    Monabati A; Vahedi A; Safaei A; Noori S; Mokhtari M; Vahedi L; Zamani M
    Asian Pac J Cancer Prev; 2016; 17(4):2285-9. PubMed ID: 27221931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr virus positive diffuse large B-cell lymphoma predict poor outcome, regardless of the age.
    Lu TX; Liang JH; Miao Y; Fan L; Wang L; Qu XY; Cao L; Gong QX; Wang Z; Zhang ZH; Xu W; Li JY
    Sci Rep; 2015 Jul; 5():12168. PubMed ID: 26202875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A retrospective analysis of primary gastric diffuse large B-cell lymphoma with or without concomitant mucosa-associated lymphoid tissue (MALT) lymphoma components.
    Li X; Xia B; Guo S; Zhan Z; Zhang L; Zhao D; Wu X; Zhang Y
    Ann Hematol; 2013 Jun; 92(6):807-15. PubMed ID: 23417758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Significance of myc gene rearrangement and its correlation with prognosis in diffuse large B cell lymphoma].
    Zhang HW; Chen ZW; He JX; Zheng YP; Han WE; Zhao ZQ; Bai W; Wang JF
    Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):119-23. PubMed ID: 23714666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term follow-up of dose-adjusted EPOCH plus rituximab (DA-EPOCH-R) in untreated patients with poor prognosis large B-cell lymphoma. A phase II study conducted by the Spanish PETHEMA Group.
    Purroy N; Bergua J; Gallur L; Prieto J; Lopez LA; Sancho JM; García-Marco JA; Castellví J; Montes-Moreno S; Batlle A; de Villambrosia SG; Carnicero F; Ferrando-Lamana L; Piris MA; Lopez A
    Br J Haematol; 2015 Apr; 169(2):188-98. PubMed ID: 25521006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.